Alliance Pharma (LON:APH) Stock Price Down 9.1%

Alliance Pharma plc (LON:APH) dropped 9.1% during mid-day trading on Wednesday . The stock traded as low as GBX 28 ($0.35) and last traded at GBX 29.10 ($0.37). Approximately 1,989,571 shares traded hands during trading, an increase of 114% from the average daily volume of 930,631 shares. The stock had previously closed at GBX 32 ($0.40).

Wall Street Analyst Weigh In

Separately, Royal Bank of Canada decreased their price target on Alliance Pharma from GBX 65 ($0.82) to GBX 60 ($0.75) and set an “outperform” rating on the stock in a research note on Wednesday, January 31st.

Alliance Pharma Price Performance

The firm has a 50-day simple moving average of GBX 36.97 and a 200 day simple moving average of GBX 38.13. The firm has a market cap of £182.93 million, a PE ratio of -3,251.10, a price-to-earnings-growth ratio of 1.04 and a beta of 0.58. The company has a debt-to-equity ratio of 45.00, a current ratio of 1.93 and a quick ratio of 1.42.

Alliance Pharma Company Profile

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.